Quantitative Systems Pharmacology models as a key to translational medicine

Ahmed, 2016, Mathematical model of Alzheimer's disease, BMC Syst Biol, 10, 108, 10.1186/s12918-016-0348-2 Ajmera, 2013, The impact of mathematical modeling on the understanding of diabetes and related complications, CPT Pharmacometrics Syst Pharmacol, 2, e54, 10.1038/psp.2013.30 Ali, 2018, Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach, Bioinformatics, 34, 1353, 10.1093/bioinformatics/btx766 Alkan, 2018, Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway, Sci Signal, 11, eaat0229, 10.1126/scisignal.aat0229 Babtie, 2017, How to deal with parameters for whole-cell modelling, J R Soc Interface, 14, 20170237, 10.1098/rsif.2017.0237 Bernard, 2012, Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development, Expert Opin Drug Metabol Toxicol, 8, 1057, 10.1517/17425255.2012.693480 Berndt, 2018, HEPATOKIN1 is a biochemistry-based model of liver metabolism for applications in medicine and pharmacology, Nat Commun, 9, 10.1038/s41467-018-04720-9 Bouhaddou, 2018, A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens, PLoS Comput Biol, 14, 10.1371/journal.pcbi.1005985 Brubaker, 2019, Computational translation of genomic responses from experimental model systems to humans, PLoS Comput Biol, 1 Chasman, 2016, Network-based approaches for analysis of complex biological systems, Curr Opin Biotechnol, 39, 157, 10.1016/j.copbio.2016.04.007 Chelliah, 2015, BioModels: ten-year anniversary, Nucleic Acids Res, 43, 542, 10.1093/nar/gku1181 Chuang, 2010, A decade of systems biology, Annu Rev Cell Dev Biol, 26, 721, 10.1146/annurev-cellbio-100109-104122 Clegg, 2015, Molecular mechanism matters: benefits of mechanistic computational models for drug development, Pharmacol Res, 99, 149, 10.1016/j.phrs.2015.06.002 Cook, 2016, Disease progression modeling: key concepts and recent developments, Current Pharmacology Reports, 2, 221, 10.1007/s40495-016-0066-x Csajka, 2006, Pharmacokinetic – Pharmacodynamic modelling : history and perspectives, J Pharmacokinet Pharmacodyn, 33, 227, 10.1007/s10928-005-9002-0 Dolgos, 2016, Translational medicine guide transforms drug development processes: the recent merck experience, Drug Discov Today, 21, 517, 10.1016/j.drudis.2016.01.003 2010 Fraser, 1995, The minimal gene complement of Mycoplasma genitalium, Science (New York, N.Y.), 270, 397, 10.1126/science.270.5235.397 Froehlich, 2018, Efficient parameter estimation enables the prediction of drug response using a mechanistic pan-cancer pathway model efficient parameter estimation enables the prediction of drug response using a mechanistic pan-cancer pathway model, Cell Syst, 7, 567, 10.1016/j.cels.2018.10.013 Fröhlich, 2018, From hype to reality: data science enabling personalized medicine, BMC Med, 16, 150, 10.1186/s12916-018-1122-7 Gadkar, 2014, A mechanistic systems pharmacology model for prediction of LDL cholesterol lowering by PCSK9 antagonism in human dyslipidemic populations, CPT Pharmacometrics Syst Pharmacol, 3, 10.1038/psp.2014.47 Glont, 2018, BioModels: expanding horizons to include more, Nucleic Acids Res, 46, 1248, 10.1093/nar/gkx1023 Ha, 2016, Prevention , and reversal of type 2 diabetes, Endocrinology, 157, 624, 10.1210/en.2015-1564 Hasenauer, 2015, Data-driven modelling of biological multi-scale processes, J. Coupled Syst. Multiscale Dyn, 3, 101, 10.1166/jcsmd.2015.1069 Hass, 2017, Predicting ligand-dependent tumors from multi-dimensional signaling features, Npj Syst Biol Appl, 1 Helmlinger, 2017, European journal of pharmaceutical sciences drug-disease modeling in the pharmaceutical industry – where mechanistic systems pharmacology and statistical pharmacometrics meet, Eur J Pharm Sci, 109, S39, 10.1016/j.ejps.2017.05.028 Froehlich, 2017, Scalable parameter estimation for genome- scale biochemical reaction networks, PLoS Comput Biol, 13 Kamburov, 2013, The consensusPathDB interaction database: 2013 update, Nucleic Acids Res, 41, 793, 10.1093/nar/gks1055 Karr, 2012, A whole-cell computational model predicts phenotype from genotype, Cell, 150, 389, 10.1016/j.cell.2012.05.044 Kirouac, 2018, How do we ‘validate’ a QSP model?, CPT Pharmacometrics Syst Pharmacol, 547, 10.1002/psp4.12310 Kirouac, 2017, Clinical responses to ERK inhibition in BRAF V600E -mutant colorectal cancer predicted using a computational model, Npj Syst Biol Appl, 2017, 1 Landersdorfer, 2008, Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus, Clin Pharmacokinet, 47, 417, 10.2165/00003088-200847070-00001 Li, 2019, Drug sensitivity prediction with high-dimensional mixture regression, PLoS One, 14, 1 Lopez, 2013, Programming biological models in python using PySB, Mol Syst Biol, 9, 1, 10.1038/msb.2013.1 Madrasi, 2018, Regulatory perspectives in pharmacometric models of osteoporosis, J Clin Pharmacol, 58, 572, 10.1002/jcph.1071 Milligan, 2013, Model-based drug development: a rational approach to efficiently accelerate drug development, Clinic Pharmacol Ther, 93 MSM Consortium. n.d.. “Interagency modeling and analysis Group (IMAG).” Https://Www.Imagwiki.Nibib.Nih.Gov/. Musante, 2017, Quantitative systems pharmacology: a case for disease models, Clinic Pharmacol Ther, 101, 24, 10.1002/cpt.528 Niz, 2016, Algorithms for drug sensitivity prediction, Algorithms, 9 Olsen, 2019, Chapter 8 – Quantitative measurements of model credibility, In Model Engineering for Simulation, 163, 10.1016/B978-0-12-813543-3.00008-1 Petrella, 2019, Computational causal modeling of the dynamic biomarker cascade in Alzheimer's disease, Comput Math Methods Med, 2019, 10.1155/2019/6216530 Rieger, 2016, Benefits and challenges of a QSP approach through case study: Evaluation of a hypothetical GLP-1/GIP dual agonist therapy, Eur J Pharm Sci, 94, 15, 10.1016/j.ejps.2016.05.006 Røge, 2017, Mathematical modelling of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 following ingestion of glucose, Basic Clin Pharmacol Toxicol, 121, 290, 10.1111/bcpt.12792 Ryu, 2015, Frequency modulation of ERK activation dynamics rewires cell fate, Mol Syst Biol, 11, 838, 10.15252/msb.20156458 Salphati, 2010, Pharmacokinetic-pharmacodynamic modeling of tumor growth inhibition and biomarker modulation by the Novel phosphatidylinositol 3-kinase inhibitor GDC-094, Drug Metab Dispos, 38, 1436, 10.1124/dmd.110.032912 Sorger, 2011, Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms an NIH white paper by the QSP Workshop Group – October, 2011, An NIH White Paper, 0 Stepanov, 2018, A mathematical model of multisite phosphorylation of tau protein, PLoS One, 13, 1 Tangherloni, 2017, 1 Todorov, 2019, Systems biology INDRA-IPM: interactive pathway modeling using natural language with automated assembly, Bioinformatics (Oxford, England), 1 Visser, 2014, Implementation of quantitative and systems pharmacology in large pharma, CPT Pharmacometrics Syst Pharmacol, 3, 1, 10.1038/psp.2014.40 Wierling, 2007, Resources, standards and tools for systems biology, Briefings Funct Genomics Proteomics, 6, 240, 10.1093/bfgp/elm027 Yamazaki, 2008, Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available CMet kinase inhibitor in human tumor xenograft mouse models, Drug Metab Dispos, 36, 1267, 10.1124/dmd.107.019711